{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:58:23Z","timestamp":1778738303938,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.neuint.2013.01.029","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T21:49:50Z","timestamp":1360014590000},"page":"379-388","source":"Crossref","is-referenced-by-count":78,"title":["Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol"],"prefix":"10.1016","volume":"62","author":[{"given":"Mohammad Moshahid","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duraisamy","family":"Kempuraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramasamy","family":"Thangavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asgar","family":"Zaheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2013.01.029_b0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brainresbull.2011.03.008","article-title":"Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice","volume":"85","author":"Acuna-Castroviejo","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuint.2013.01.029_b0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.2002.tb02905.x","article-title":"Chemistry of the antioxidant effect of polyphenols","volume":"957","author":"Bors","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuint.2013.01.029_b0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/B978-0-12-381328-2.00005-5","article-title":"New approaches to therapy","volume":"98","author":"Brotchie","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuint.2013.01.029_b0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2008.05.116","article-title":"Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile","volume":"441","author":"Cheng","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2013.01.029_b0030","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1523\/JNEUROSCI.0970-05.2005","article-title":"Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson\u2019s disease in mice","volume":"25","author":"Choi","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2013.01.029_b0035","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.neuropharm.2011.01.043","article-title":"Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation","volume":"60","author":"Chung","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2013.01.029_b0040","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.fitote.2010.06.011","article-title":"Pycnogenol: a blend of procyanidins with multifaceted therapeutic applications?","volume":"81","author":"D\u2019Andrea","year":"2010","journal-title":"Fitoterapia"},{"key":"10.1016\/j.neuint.2013.01.029_b0045","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.2000.0742213.x","article-title":"Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo","volume":"74","author":"Dehmer","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2013.01.029_b0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mds.870090115","article-title":"Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study","volume":"9","author":"Dexter","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2013.01.029_b0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0301-0082(99)00060-X","article-title":"Metabolism and functions of glutathione in brain","volume":"62","author":"Dringen","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2013.01.029_b0060","first-page":"412","article-title":"Biology of disease: free radicals and tissue injury","volume":"47","author":"Freeman","year":"1982","journal-title":"Lab. Invest."},{"key":"10.1016\/j.neuint.2013.01.029_b0065","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"Gao","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2013.01.029_b0070","doi-asserted-by":"crossref","first-page":"18754","DOI":"10.1073\/pnas.0704908104","article-title":"Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease","volume":"104","author":"Ghosh","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2013.01.029_b0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-2001-3308","article-title":"Abnormalities in oxidative processes in non-neuronal tissues from patients with Alzheimer\u2019s disease","volume":"3","author":"Gibson","year":"2001","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2013.01.029_b0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1742-2094-9-82","article-title":"Proteolytic activation of proapoptotic kinase protein kinase Cdelta by tumor necrosis factor alpha death receptor signaling in dopaminergic neurons during neuroinflammation","volume":"9","author":"Gordon","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neuint.2013.01.029_b0085","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0891-5849(99)00168-9","article-title":"Electron spin resonance study of free radicals formed from a procyanidin-rich pine (Pinus maritima) bark extract, pycnogenol","volume":"27","author":"Guo","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2013.01.029_b0090","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.pnpbp.2011.01.017","article-title":"Targeting oxidative stress, mitochondrial dysfunction and neuroinflammatory signaling by selective cyclooxygenase (COX)-2 inhibitors mitigates MPTP-induced neurotoxicity in mice","volume":"35","author":"Gupta","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2013.01.029_b0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","article-title":"Oxidative stress and inflammation in Parkinson\u2019s disease: is there a causal link?","volume":"193","author":"Hald","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2013.01.029_b0100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","article-title":"The role of glial reaction and inflammation in Parkinson\u2019s disease","volume":"991","author":"Hirsch","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuint.2013.01.029_b0105","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2013.01.029_b0110","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuint.2013.01.029_b0115","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","article-title":"Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease","volume":"94","author":"Hunot","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2013.01.029_b0120","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/FBP.0b013e32832c7125","article-title":"Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats","volume":"20","author":"Ishrat","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuint.2013.01.029_b0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2013.01.029_b0130","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1016\/S1353-8020(11)70057-8","article-title":"Animal models of Parkinson\u2019s disease","volume":"18","author":"Jackson-Lewis","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuint.2013.01.029_b0135","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/ptr.2776","article-title":"Pycnogenol efficiency on glycaemia, motor nerve conduction velocity and markers of oxidative stress in mild type diabetes in rats","volume":"23","author":"Jankyova","year":"2009","journal-title":"Phytother. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2013.01.029_b0305","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/ana.410320714","article-title":"Oxidative stress as a cause of nigral cell death in Parkinson\u2019s disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson\u2019s Disease Research Group","volume":"32","author":"Jenner","year":"1992","journal-title":"Ann. Neurol."},{"issue":"Suppl. 3","key":"10.1016\/j.neuint.2013.01.029_b0310","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson\u2019s disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2013.01.029_b0150","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.bbrc.2005.04.036","article-title":"Anti-oxidant and anti-inflammatory activities of macelignan in murine hippocampal cell line and primary culture of rat microglial cells","volume":"331","author":"Jin","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2013.01.029_b0155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2008.10.005","article-title":"Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson\u2019s disease in rats","volume":"600","author":"Jin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2013.01.029_b0160","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1471-4159.2009.05999.x","article-title":"The inflammatory response in the MPTP model of Parkinson\u2019s disease is mediated by brain angiotensin: relevance to progression of the disease","volume":"109","author":"Joglar","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2013.01.029_b0165","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/FBP.0b013e32833d4186","article-title":"Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinson\u2019s disease","volume":"21","author":"Khan","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuint.2013.01.029_b0170","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/STROKEAHA.111.635516","article-title":"Alternatively-spliced extra domain a of fibronectin promotes acute inflammation and brain injury after cerebral ischemia in mice","volume":"43","author":"Khan","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2013.01.029_b0175","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.brainres.2010.10.023","article-title":"Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies","volume":"1368","author":"Khuwaja","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.01.029_b0180","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.fct.2011.06.012","article-title":"Pycnogenol modulates apoptosis by suppressing oxidative stress and inflammation in high glucose-treated renal tubular cells","volume":"49","author":"Kim","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuint.2013.01.029_b0185","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/emm.2006.40","article-title":"Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease","volume":"38","author":"Kim","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuint.2013.01.029_b0190","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.fct.2010.10.029","article-title":"Astaxanthin protects against MPTP\/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro","volume":"49","author":"Lee","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuint.2013.01.029_b0200","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jep.2010.10.041","article-title":"A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract","volume":"133","author":"Maimoona","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuint.2013.01.029_b0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jbt.10078","article-title":"Source Effects of pycnogenol treatment on oxidative stress in streptozotocin-induced diabetic rats","volume":"17","author":"Maritim","year":"2003","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.neuint.2013.01.029_b0210","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12640-009-9037-x","article-title":"Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease by blocking microglial activation","volume":"15","author":"Moon","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuint.2013.01.029_b0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cnr.2006.09.006","article-title":"Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson\u2019s Disease","volume":"6","author":"Mosley","year":"2006","journal-title":"Clin. Neurosci. Res."},{"issue":"Suppl. 3","key":"10.1016\/j.neuint.2013.01.029_b0220","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1016\/S1353-8020(09)70814-4","article-title":"Neuroinflammation in the living brain of Parkinson\u2019s disease","volume":"15","author":"Ouchi","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuint.2013.01.029_b0225","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0891-5849(99)00090-8","article-title":"Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol","volume":"27","author":"Packer","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2013.01.029_b0320","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00709-012-0418-2","article-title":"Modulatory effects of Pycnogenol\u00ae in a rat model of insulin-dependent diabetes mellitus: biochemical, histological, and immunohistochemical evidences","volume":"250","author":"Parveen","year":"2013","journal-title":"Protoplasma"},{"key":"10.1016\/j.neuint.2013.01.029_b0235","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s000180050045","article-title":"Pycnogenol inhibits tumor necrosis factor-alpha-induced nuclear factor kappa B activation and adhesion molecule expression in human vascular endothelial cells","volume":"57","author":"Peng","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuint.2013.01.029_b0240","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.freeradbiomed.2011.12.003","article-title":"Pycnogenol attenuates the inflammatory and nitrosative stress on joint inflammation induced by urate crystals","volume":"52","author":"Peng","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2013.01.029_b0245","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5414\/CPP40158","article-title":"A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology","volume":"40","author":"Rohdewald","year":"2002","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2013.01.029_b0315","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008294.pub4","article-title":"Pycnogenol(R) (extract of French maritime pine bark) for the treatment of chronic disorders((R)) for the treatment of chronic disorders","volume":"4","author":"Schoonees","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuint.2013.01.029_b0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0006-8993(91)90170-Z","article-title":"Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections","volume":"554","author":"Schwarting","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.01.029_b0260","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.nbd.2009.12.010","article-title":"Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms","volume":"37","author":"Shen","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2013.01.029_b0265","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0891-5849(90)90156-D","article-title":"Free radicals, antioxidant enzymes, and carcinogenesis","volume":"8","author":"Sun","year":"1990","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2013.01.029_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory mechanisms in Parkinson\u2019s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention","volume":"208","author":"Tansey","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2013.01.029_b0275","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson\u2019s disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuint.2013.01.029_b0280","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neuroscience.2009.02.037","article-title":"Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer\u2019s disease","volume":"160","author":"Thangavel","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2013.01.029_b0285","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2013.01.029_b0290","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.nbd.2008.02.011","article-title":"Nociceptin\/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism","volume":"30","author":"Viaro","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2013.01.029_b0295","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2013.01.029_b0300","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.fct.2007.08.016","article-title":"Protective effects of Pycnogenol on carbon tetrachloride-induced hepatotoxicity in Sprague-Dawley rats","volume":"46","author":"Yang","year":"2008","journal-title":"Food Chem. Toxicol."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018613000387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018613000387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T20:34:37Z","timestamp":1539894877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018613000387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0197018613000387"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2013.01.029","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}